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BACKGROUND AND PURPOSE: Little has been known about the clinical and angiographic follow-up
results of stent-only therapy for intracranial vertebrobasilar dissecting aneurysms (VBDA). The purpose
of this study was to evaluate the feasibility, safety, clinical, and angiographic follow-up of stent-only
therapy for VBDA.
MATERIALS AND METHODS: Twenty-seven patients with 29 VBDAs (11 ruptured, 18 unruptured), not
suitable for deconstructive treatment, underwent stent-only therapy. Feasibility, safety, clinical, and
angiographic follow-up were retrospectively evaluated. Angiographic outcomes were compared be-
tween single-stent and multiple-stent groups.
RESULTS: All attempted stent placements were successfully accomplished without any treatment-
related complication. Of the 11 ruptured VBDAs, 4 were treated by single stents, 6 by double
overlapping stents, and 1 by triple overlapping stents. Of the 18 unruptured VBDAs, 6 were treated by
stents, and 12 by double overlapping stents. One patient with a ruptured VBDA, treated by single
stent, had rebleeding and died. None of the remaining patients had posttreatment bleeding during
follow-up (mean, 28 months; range, 7–50 months). Eight patients with ruptured VBDA and all patients
with unruptured VBDA had excellent outcomes (modified Rankin Scale, 0–1). The remaining 2 patients
with ruptured VBDA were moderately disabled because of the initial damage. Angiographic follow-up
was available in 27 VBDAs, 4 to 42 months (mean, 12 months) after treatment. Follow-up angiograms
revealed complete obliteration of the dissecting aneurysm in 12, partial obliteration in 12, stable in 1,
enlargement in 1, and in-stent occlusion in 1. Angiographic improvement (complete or partial obliter-
ation) was more frequent in the multiple-stent group (17/17) than in the single-stent group (7/9; P 
.05).
CONCLUSIONS: In this small series, stent-only therapy was safe and effective in the treatment of
VBDAs that were not deemed suitable for treatment with parent-artery occlusion.
Acute intracranial vertebrobasilar dissecting aneurysm(VBDA) is a well-known cause of acute subarachnoid
hemorrhage (SAH) or ischemic stroke of the posterior circu-
lation.Most rupturedVBDAs can be treated by deconstructive
treatments, which sacrifice the parent artery to obliterate the
dissecting aneurysm.1-4 However, how to manage a ruptured
VBDA, which is not suitable for deconstructive treatment, is
not well established. Also, there has been controversy on how
to manage an unruptured VBDA. Recently, reports of stent-
only therapy, a new option for the treatment of VBDA, are
increasing.5-14 However, to our knowledge, little has been
known about the clinical and angiographic follow-up results
of stent-only therapy for VBDA. The purpose of this study was
to retrospectively evaluate the feasibility, safety, and clinical
and angiographic follow-up of stent-only therapy for VBDAs,
which were not suitable for deconstructive treatment.
Materials and Methods
Patients
Our institutional review board approved this retrospective study, and
informed patient consent was waived. The diagnosis of VBDA was
based on clinical manifestations and findings of radiologic examina-
tions including CT with CT angiography, MR imaging with MR an-
giography, and conventional angiography. Clinical manifestations
suggestive of VBDA included SAH, ischemic symptoms of the brain
stem, and/or posterior headache of sudden onset. Radiologic findings
of VBDA included symmetric or asymmetric dilation of the affected
segment of the vertebrobasilar artery with or without proximal or
distal stenosis plus any of the following findings: intramural hema-
toma, pearl-and-string sign, double-lumen sign, configurational
change of the affected segment on serial imaging follow-up, and con-
trast media stasis at the affected segment on conventional angiogra-
phy. Incidentally found radiologic abnormalities of the vertebrobasi-
lar artery, whichmight be suggestive of arterial dissection but without
corresponding clinical symptoms, were excluded because the lesions
were not thought to be acute dissection but, rather, chronic dissection
or other pathologic condition of the artery.
A total of 108 patients with 113 VBDAs (59 ruptured and 54 un-
ruptured) were identified at 3 institutions between January 2001 and
October 2007. Six patients had bilateral vertebral artery dissections
(11 dissecting aneurysms and 1 stenotic vertebral artery dissection).
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Among the 113 VBDAs with aneurysmal dilation, 25 VBDAs were
conservatively managed, 38 were treated by parent-vessel occlusion
(internal coil trapping or proximal occlusion), 21 were treated by
single or double stent(s) with coiling, and 29 VBDAs in 27 patients
were treated by stent-only therapy. These 27 patients constituted the
population of this study. The patients included 17men and 10women
(mean age, 46 years; age range, 24–71 years). Eleven patients pre-
sented with SAH, 10 with posterior headache of sudden onset, 5 with
brain stem infarct, and the remaining 1 with brain stem compression
sign 3 years after stem infarct. Two patients had bilateral vertebral
dissecting aneurysms: 1 presented with SAH, and the other presented
with posterior headache of sudden onset. The 27 patients with VBDA
included in our study were treated by stent-only therapy, not by de-
constructive treatment, because of involvement of the basilar artery
(BA) in 4, involvement of the vertebral arterial segment bearing the
origin of the dominant posterior inferior cerebellar artery (PICA)
with relatively small size of the anterior inferior cerebellar artery
(AICA) in 21, or involvement of bilateral vertebral arterial segments
bearing the origin of the PICA in 2.
Antiplatelet Medication and Anticoagulation
Dual antiplatelet therapy (acetylsalicylic acid plus clopidogrel) was
routinely given to the patients with unruptured acute intracranial
VBDA before and after stent placement, except for 1 patient who was
treated in the early period of the collected cases. For the patients with
ruptured acute intracranial VBDA, antiplatelet premedication was
not given, but a loading dose of dual antiplatelet therapy was given
immediately after completion of the procedure. Dual antiplatelet
therapy was maintained for 3 to 6 months and then was changed to
aspirin monotherapy indefinitely. Anticoagulation was started at the
beginning of the procedure, and activated coagulation time was
maintained 2 to 3 times the baseline value during the procedure and
for 24 to 48 hours after the procedure.
Stent Placement for VBDA
A6F guiding catheter (Envoy; Cordis,Miami Lakes, Fla) was placed at
the cervical portion of the affected vertebral artery. A microcatheter
(Excelsior-10; Boston Scientific, Natick,Mass, or Prowler-14, Cordis)
was navigated to a distal branch of the posterior cerebral artery with
use of a 0.014-inch wire (Synchro, Boston Scientific; or Agility, Cor-
dis), which was then exchanged with a 300-cm-length exchangeable
guidewire (Transcend or Choice-PT, Boston Scientific). The micro-
catheter was retrieved and a balloon-expandable stent or a self-ex-
panding stent was advanced over the prepositioned exchangeable
guidewire and was deployed covering the entire dissected segment.
The types of stents were determined according to the operator’s pref-
erence, availability of the stent, and the degree of difference of the
vessel diameter between the proximal and distal portions of the af-
fected segment. The number of overlapping stents was determined
according to the location of the dissection of the vertebral artery or the
basilar artery, tortuousness of the parent artery, and findings on con-
trol angiogram just after deployment of the first stent. Technical suc-
cess was defined by correct placement of the stent(s). The stents used
included a self-expanding Neuroform stent (Boston Scientific) and
various types of balloon-expandable coronary stents (Vision,
Guidant, St. Paul, Minn; FlexMaster, JOMED, Rangendingen, Ger-
many; Driver,Medtronic,Minneapolis,Minn; Zeta, Abbott Vascular,
Santa Clara, Calif).
Clinical Assessment and Angiographic Follow-up
The patients were clinically assessed on admission with the Hunt and
Hess grading system andwere evaluated for complications during and
after treatment. Clinical outcomewas evaluated at discharge and clin-
ical follow-up according to the modified Rankin Scale score (mRS).
Each patient’s clinical status at the last clinical follow-up was defined
as the final outcome.
Angiographic follow-upwas available at least once in 27VBDAs in
25 patients at 4 to 42months (mean, 12months) after treatment. The
degree of obliteration of the dissecting aneurysmal sac was evaluated
by an interventional neuroradiologist, who was not involved in the
treatment, and classified into 4 categories: 1) complete obliteration if
the dissecting aneurysmal sac was completely obliterated, 2) partial
obliteration if the dissecting aneurysmal sac remarkably decreased in
size but remained, 3) stable if the dissecting aneurysmal sac showed
no remarkable interval change in size and configuration, and 4) ag-
gravation if the dissecting aneurysmal sac increased in size. In-stent
occlusion or in-stent stenosis, and patency of the branch vessel or the
perforators covered by stents were also evaluated on follow-up
angiography.
Statistics
We performed statistical analyses using SPSS for Windows (Version
12.0; SPSS, Chicago, Ill). We then compared angiographic follow-up
results of 26 VBDAs except for 3 VBDAs (2 without angiographic
follow-up and 1 in-stent occlusion) between single-stent (n 9) and
multiple-stent (double or triple, n 17) groups or between ruptured
(n 9) and unruptured (n 17) groups by using the 2-sided 2 test.
For comparison, angiographic follow-up results were dichotomized
to improvement (complete or partial obliteration) or no improve-
ment (stable or aggravated). Statistical significance was determined
by P .05 for a 95% confidence interval.
Results
Clinical characteristics and clinical and angiographic fol-
low-up results of the patients are summarized in On-line Ta-
ble 1. Attempted stent placement was successfully accom-
plished without any treatment-related complication in all of
the 29 VBDAs in 27 patients.
Of the 11 ruptured VBDAs, 4 were treated by single stent, 6
by double overlapping stents (Fig 1), and 1 by triple overlap-
ping stent (Fig 2).Of the 18 unrupturedVBDAs, 6were treated
by single stent and 12 by double stents.
One patient with a ruptured basilar dissecting aneurysm,
who underwent single-stent placement, had rebleeding 3 days
after treatment and died (Fig 3). Because of a concern about
perforator obstruction and a favorable finding on control an-
giogram just after single-stent placement (Fig 3B), a second
stent insertion was not attempted. None of the surviving 26
patients had posttreatment bleeding during the clinical fol-
low-up for 7 to 50 months (mean, 28 months). Eight patients
with rupturedVBDAhad excellent outcomes (mRS, 0–1). The
remaining 2 patients with ruptured VBDA were disabled be-
cause of the initial damage (mRS, 3 and 4, respectively). All 16
patients with unrupturedVBDAhad excellent outcomeswith-
out any neurologic deficit (mRS, 0).
On-line Table 2 summarizes the follow-up angiographic
results of the VBDAs treated by stent only according to pre-
sentation and number of overlapping stents. Follow-up angio-
gram revealed complete obliteration of the VBDA in 12 aneu-
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rysms, partial obliteration in 12, stable in 1, and aggravation in
1. Angiographic improvement (complete or partial oblitera-
tion) was more frequently observed in the multiple-stent
group (17/17 [100%]) than in the single-stent group (7/9
[77.8%]; P .05) but was not significantly different between
the ruptured group (9/9 [100%]) and the unruptured group
(15/17 [88.2%]). We determined to carefully follow up on the
VBDA with aggravation because the dissecting aneurysm was
unruptured and the patient refused additional treatment. In-
stent occlusion was detected on a 4-month follow-up angio-
gram in 1 unruptured basilar artery dissecting aneurysm
treated by double overlapping stents, and the case was pre-
sented in a previously published report.14 The remaining 26
VBDAs showed no in-stent stenosis, occlusion of the PICA, or
the perforators jailed by the stent.
Discussion
Acute VBDA can present with SAH, brain stem ischemia,
and/or sudden posterior headache. Various endovascular
methods have been used to treat the VBDA, which include
proximal occlusion of the parent artery, internal coil oblitera-
tion or trapping of the dissected segment of the parent artery,
stent-assisted coiling, stent-only therapy with single or multi-
ple stents, and covered stent.1-18 However, for the VBDA not
suitable for deconstructive treatments that occludes the parent
artery, the appropriate treatment method has not been well
established. In patients who had basilar dissecting aneurysms
or dominant vertebral dissecting aneurysms with poor collat-
erals, internal coil trapping cannot be applied. In patients with
ruptured dissecting aneurysms involving the segment bearing
PICA origin, proximal occlusion of the parent artery is an
option, but this technique does not protect from rebleeding
because of retrograde flow to the dissected segment.3,19-22 In-
ternal coil trapping including the PICA origin may also be
considered, especially in acute situations. Pelluso et al4 re-
ported successful treatment of 2 patients with ruptured verte-
bral dissections by internal coil trapping including the PICA
origin. Those 2 patients had no clinical complication related to
Fig 1. Images in a 42-year-old man presenting with an acute SAH. A, Left vertebral artery angiogram reveals a dissecting aneurysm with an asymmetrically fusiform appearance at the
segment-bearing left posterior inferior cerebellar artery. At 42 months after treatment with double overlapping stents, a left vertebral angiogram (B ) and 3D reconstruction images (C ) show
complete obliteration of the dissecting aneurysm sac with preservation of the left PICA.
Fig 2. Images in a 49-year-old man presenting with an acute SAH. A, Right vertebral angiogram reveals irregular dilation of the right intracranial vertebral artery with a pearl-and-string
appearance, involving the origin of the right PICA. B, Right vertebral angiography 4 days after double-overlapping stent insertion shows partial resolution of the pearl-and-string appearance
but reveals enlarged fusiform dilation of the dissected segment. C, Six-month follow-up angiogram after third overlapping stent reveals complete obliteration of the fusiform dilation with
a preserved PICA and smooth reconstruction of the dissected segment.
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the PICA occlusion. Also, the same authors reported 6 aneu-
rysms at the PICA origin that were treated by coil occlusion,
including the parent PICA in 2 and the VA and PICA origin in
4.23 Lateral medullary and cerebellar infarction leading to
hemiparesis developed in 1 of the 6 patients. These reports
suggest that PICA occlusion may be more tolerable than ex-
pected. However, it was difficult to predict the consequence of
PICA occlusion in ruptured vertebral dissection. In our expe-
rience and personal communication with the neurointerven-
tional radiologist colleagues in our country, internal coil trap-
ping including the PICA origin in ruptured vertebral artery
dissections resulted in significant complications in 2 of 3 pa-
tients, including amassive cerebellar infarction requiring pos-
terior craniectomy for decompression. Additional study on
internal coil trapping including the PICA origin for treatment
of ruptured vertebral artery dissections may be required.
Therefore, our treatment policy was to select the method that
did not sacrifice the PICA even in ruptured VBDA involving
the PICA origin, unless the ipsilateral AICA was definitely
dominant over the PICA.
Recently, much interest has centered on reconstructive en-
dovascular treatment with use of a stent for an intracranial
dissecting aneurysm or pseudoaneurysm. Since Lylyk et al15
reported a case of stent-only therapy for bilateral VA dissect-
ing aneurysms included in a series of stent-assisted coil embo-
lization, an increasing number of cases of stent-only therapy
were reported (On-line Table 3).5-8,10-13,15-17,24,25 However,
little has been known about the clinical and angiographic fol-
low-up results of stent-only therapy for VBDAs. The present
study, to the best of our knowledge, includes the largest num-
ber of the VBDAs treated by stent only.
In review of the literature, 38 intracranial VBDAs, 4 blood-
blisterlike aneurysms, and 3 postsurgical pseudoaneurysms in
43 patients were treated by stent-only therapy (On-line Table
3). Two (4.7%) of the 43 patients had a treatment-related
complication of occipital infarction, resulting in partial visual
field deficit.10,13 In our study, a technical success rate of 100%
was achieved with no treatment-related complications. These
findings suggest that stent-only therapy is a technically feasible
and safe treatment option for VBDA. Among the 43 patients,
43 aneurysms in 41 patients were followed up with angiogra-
phy 1 to 18 months after treatment. Of those, 31 (72.1%) re-
vealed complete obliteration of the dissecting aneurysm or
pseudoaneurysm sac, 6 (14.0%) revealed partial obliteration, 1
(2.3%) was stable, 2 (4.7%) were enlarged, 1 (2.3%) had re-
canalization after near-complete obliteration, and 2 (4.7%)
had in-stent occlusion. The rate of complete obliteration in
our series was lower than that reported in the literature (41.4%
vs 71.4%). However, the rate of angiographic improvement
(complete or partial obliteration) of our study was similar to
that reported in the literature (82.8% vs 86.1%). Angiographic
improvement (complete or partial obliteration) was signifi-
cantly more frequent in the multiple-stent group than in the
single-stent group. This finding suggests that multiple over-
lapping stents may be more effective for obliteration of a dis-
secting aneurysm sac than a single stent.
In the literature, 2 (4.7%) of 43 cases with follow-up an-
giography revealed in-stent occlusion, of which 1 patient died
from brain stem infarction.10,25 In our study, 1 (3.7%) of 27
cases with follow-up angiography also showed in-stent occlu-
sion. Of the 3 patients in the literature and in our study, 2 did
not receive antiplatelet medication, and the third patient was
not compliant with antiplatelet medication. These suggest
once again that appropriate antiplatelet medication should be
mandatory for all patients who have undergone stent place-
ment. The possibility of the occlusion of the branch vessels or
the perforators covered by the stent is another major concern
in stent therapy, especially for the perforator-rich vertebro-
basilar system. Fortunately, in this study and in the literature,
there was no occlusion of the branch vessels or of the perfora-
tors jailed by the stents. These correspond with in vivo re-
search datawith high-porosity stents and the hypothesis that if
the pressure gradient across the perforators is maintained and
the perforator is covered less than 50% by stent struts, the
arteries will remain patent and will remodel around the
struts.17,26-30
There has been a controversy on whether unruptured
VBDAs should be treated or conservatively managed. Because
of the retrospective nature of our study, it was determined
according to each institution’s policy and the patient’s choice
whether the unruptured VBDA was treated. In our study,
none of the unruptured VBDAs bled during follow-up. This
may be owing to either the nature of the unruptured VBDA or
the effect of stent therapy. To establish an appropriate algo-
Fig 3. Images in a 24-year-old woman presenting with SAH. A, Left vertebral angiogram reveals an asymmetrical fusiform dilation with a bleb (white arrow) of the basilar artery. B, Left
vertebral angiogram immediately after a balloon-expandable coronary stent insertion reveals near-complete obliteration of the dissecting aneurysm sac. C, Left vertebral angiogram
performed because of rebleeding 3 days after the single-stent placement shows an irregular-shaped and enlarged pseudoaneurysm (black arrow) of the basilar artery.
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rithm for the management of unruptured VBDAs, a prospec-
tive study with a larger population of unruptured VBDAsmay
be required.
In animal aneurysm models, stent-only therapy revealed
very encouraging results.29-34 In experimental studies with
particle image velocimetry and computational flow dynamics,
a stent decreases inflow complexity, inflow momentum and
velocity, vorticity, wall shear stress, and wall shear stress rate,
and increases intra-aneurysmal blood turnover time by divert-
ing blood flow from the aneurysm and by dispersing the in-
flow into the aneurysm sac.35-43 These hemodynamic changes
induced by the stent may help to prevent aneurysmal rupture
or growth. The hemodynamics can bemore favorably changed
by decreasing stent porosity and straightening the curvature of
the parent vessel segment bearing the aneurysm.38-43 Stents
may work more effectively in vivo than expected in experi-
mental flow dynamic models. Because the vessel is not a rigid
pipe, the stent may correct the aneurysm neck-parent artery
angle and thereby induce more favorable hemodynamic
changes.13 Also, the vessel wall may interact with the stent,
resulting in tissue response at the vessel wall and the aneurysm
neck,30,44,45 which may promote healing response of the dis-
sected vessel wall. Both cases (1 in the literature and 1 in our
series), which rebled after stent-only therapy, were located at
the basilar artery and underwent single-stent placement.24
Relatively higher porosity of the single stent and less effective
angle correction of the BAmight be responsible for rebleeding
in the acute phase. The introduction of a newly designed stent
with low porosity such as a pipeline may help to overcome
limitations of a high-porosity stent and play a pivotal role in
the treatment of a dissecting aneurysm as well as of a saccular
aneurysm.30,46
Conclusions
Stent-only therapy was safe and effective in the treatment of
VBDAs that were not deemed suitable for treatment with par-
ent artery occlusion. Multiple overlapping stents seem to be
more effective in the obliteration of the dissecting aneurysm
sac than a single stent.
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